When you need
to be sure

In the first half of 2026, we achieved strong organic growth, further margin expansion and record cash generation.

Géraldine reflects on the excellent half year results and the key achievements in H1.

Understand TRACES, EUDR due diligence statements and how to prepare your company.

Using advanced mass spectrometry to ensure safer pharmaceutical packaging and medical devices.

Tailored solutions help organizations meet evolving regulatory obligations and uphold critical brand integrity.